| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jul 2, 2009
Eisai Co., Ltd. (Headquarters: Tokyo, President & CEO: Haruo Naito, "Eisai") and Eisai Corporation of North America (Headquarters: Woodcliff Lake, NJ, Chairman and CEO Hajime Shimizu) are...
-
Jul 1, 2009
Morphotek®, Inc., a subsidiary of Eisai Corporation of North America, announced a research collaboration agreement with Synageva BioPharma Corporation to express and develop therapeutic...
-
Jun 9, 2009Antibody Targets Endosialin, a Protein Widely Expressed on Tumors and Tumor Blood Vessel Cells
Morphotek®, Inc., a subsidiary of Eisai Corporation of North America, announced that the U.S. Food and Drug Administration (FDA) cleared its investigational new drug (IND) application to study...
-
Jun 1, 2009Eisai Inc. and the Alzheimer's Association Support Award to Recognize Critical Role of Pharmacists in Alzheimer's Care
Eisai Inc., in coordination with the Alzheimer's Association, calls on individuals with Alzheimer's disease and their caregivers across America to nominate local pharmacists for the 2009 C.A.R.E....
-
Dec 9, 2008Award Recognizes Critical Need for Deep Vein Thrombosis (DVT) Prophylaxis in Hospitals
Eisai Inc., in coordination with the North American Thrombosis Forum (NATF), introduced today the DVTeamCare Hospital Award. This new award provides national recognition to hospitals that have...
-
Dec 27, 2007
Eisai Co., Ltd. (Headquarters: Tokyo, President and CEO: Haruo Naito) and Eisai Inc. (Headquarters: New Jersey, Chairman and CEO: Hajime Shimizu) (collectively "Eisai") filed a lawsuit in August...
-
Oct 24, 2007Eisai Holds Dedication Ceremony to Commemorate New U.S. Corporate Headquarters in Woodcliff Lake, NJNew Facility Supports Company's Ongoing Expansion and Growth
Eisai Corporation of North America and Eisai Inc. today hosted a dedication ceremony to commemorate the opening of its newly constructed U.S. corporate headquarters in Woodcliff Lake, NJ. Eisai...
-
Sep 5, 2007Agreement Complements Eisai's Presence in Gastroenterology and Primary Care
Eisai Inc., a U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., today announced the signing of a U.S. copromotion agreement with Salix Pharmaceuticals, Ltd. in which Eisai receives...
